LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States.

In this article, Intermountain Healthcare transplant surgeons perform the first ever liver transplants in Utah with organs preserved by the LifePort^® Liver Transporter during the clinical trial, PILOT. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a prospective randomized multi-center oxygenated hypothermic machine perfusion study using the LifePort Liver Transporter (LLT) system as compared to static cold storage in orthotopic liver transplantation.

_.

“The primary objective of this study is to collect clinical data to provide reasonable assurance of safe and effective use of transporting livers for our transplant patients,” said Dr. Diane Alonso. “In the long run, we hope to use this technology in the future to increase the number of organs available for transplantation, while reducing complications and shortening the length of hospital stays.”

Intermountain Healthcare is a not-for-profit health system with a team of more than 41,000 caregivers based in Salt Lake City, Utah who serve the healthcare needs of people across Utah, Idaho, and Nevada.